Pharmacokinetics and Safety in Healthy Volunteers

NCT02045979 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

327

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BI 695501
DRUG: adalimumab-EU source
DRUG: adalimumab-US source

Sponsor

Boehringer Ingelheim